channel blocker Ni 2ϩ reduced the store depletion-activated Ca 2ϩ currents, decreased CCE, and inhibited the CCE-mediated contraction. In single PASMCs, we identified, using RT-PCR, five transient receptor potential gene transcripts. These results suggest that CCE, potentially through transient receptor potential-encoded Ca 2ϩ channels, plays an important role in agonist-mediated PA contraction. transient receptor potential gene; pulmonary hypertension; pulmonary artery smooth muscle cells EXCESSIVE PULMONARY VASOCONSTRICTION and elevated circulating vasoactive agonists have been implicated in pulmonary hypertension (7, 12, 28, 40) . An increase in the cytosolic free Ca 2ϩ concentration ([Ca 2ϩ ] cyt ) in pulmonary artery (PA) smooth muscle cells (SMCs) is a major trigger for pulmonary vasoconstriction when the vessels are stimulated by vasoactive agonists such as L-phenylephrine (PE) (9) and serotonin (30) . The two sources of increased cytosolic Ca 2ϩ on activation of various membrane receptors are 1) intracellular Ca 2ϩ stores, mainly the sarcoplasmic reticulum (SR) in muscle cells, and 2) extracellular Ca 2ϩ that enters the cell through opened Ca 2ϩ -permeable channels in the plasma membrane (8, 37) . The SR in SMCs has a limited capacity for Ca 2ϩ storage. Therefore, the receptor activation-mediated Ca 2ϩ mobilization depletes the internal stores, which have to be replenished through the entry of Ca 2ϩ from the extracellular milieu. Indeed, depletion of Ca 2ϩ from the SR due to agonist-induced Ca 2ϩ release triggers Ca 2ϩ influx, referred to as capacitative Ca 2ϩ entry (CCE) (31) . Store depletion-mediated CCE is therefore a critical mechanism for refilling the empty SR with Ca 2ϩ and maintaining a sustained increase in [Ca 2ϩ ] cyt (5, 29) . In single vascular SMCs in vitro, agonist-mediated changes in [Ca 2ϩ ]cyt consist of a transient increase in [Ca 2ϩ ] cyt due to Ca 2ϩ release from the SR and a sustained increase in [Ca 2ϩ ] cyt due to Ca 2ϩ influx through sarcolemmal Ca 2ϩ channels. There are at least three classes of Ca 2ϩ -permeable channels: 1) store-operated Ca 2ϩ channels (SOCs) (29) , 2) receptor-operated Ca 2ϩ channels (ROCs) (11, 37) , and 3) voltage-dependent Ca 2ϩ channels (VDCCs) (24) . Agonist-induced Ca 2ϩ influx is caused mainly by receptormediated activation of ROCs and store depletionmediated opening of SOCs (5, 29, 37) . Membrane depolarization-mediated activation of VDCCs has also been implicated in agonist-induced increases in [Ca 2ϩ ] cyt (8, 24) . Electrophysiological studies on the store depletionactivated CCE current, also termed SOC current (I SOC ), indicate that there are multiple types of SOCs with different single-channel conductances (19, 20) . It has recently been demonstrated that a novel gene family, transient receptor potential (TRP), is essential for encoding putative Ca 2ϩ -permeable cation channels responsible for agonist-activated CCE (5, 26, 45) . Expression of TRP genes in Xenopus oocytes or mammalian cell lines does, indeed, result in the formation of Ca 2ϩ channels that are activated by Ca 2ϩ store depletion. These findings suggest that SOCs may be composed of subunits encoded in TRP genes (5, 20, 45) .
In PASMCs, production of inositol 1,4,5-trisphosphate [Ins(1,4,5)P 3 ] and diacylglycerol is a common mechanism by which vasoactive agonists raise [Ca 2ϩ ] cyt (5, 8) . The Ins(1,4,5)P 3 -sensitive SR serves as an im-portant source for agonist-mediated Ca 2ϩ release into the cytoplasm (36) , whereas the diacylglycerol-mediated opening of ROCs and VDCCs (8, 37) is an important pathway for Ca 2ϩ entry from the extracellular milieu. The contribution of CCE to the agonist-mediated vasomotor tone has been elucidated only recently (13, 27, 42) . The role of CCE and SOCs in agonistmediated pulmonary vasoconstriction and the molecular identity of SOCs in PASMCs, however, are still incompletely understood. This study was designed to test the hypothesis that agonist-mediated increases in [Ca 2ϩ ] cyt due to CCE through TRP-encoded SOCs participate in producing vasoconstriction in isolated rat PAs.
MATERIALS AND METHODS
Isolation of PA rings. The right branch of the main PA was isolated from male Sprague-Dawley rat (100-125 g) lung tissues. The adipose and connective tissues were carefully stripped off with fine forceps, and the remaining PAs were then cut into 2-mm-long rings. In some of the experiments, the endothelium of the PA rings was removed by gently rubbing the inner lumen of the vessels with a rough wooden stick. This procedure appeared not to damage the vessels because high K ϩ -mediated contractions did not differ significantly between PA rings with and without endothelium.
Tension measurement. Two stainless steel hooks (0.1-mm diameter) were inserted through the lumen of the rings. One hook was mounted in a perfusion chamber (0.75-ml volume), and the other hook was connected to an isometric force transducer (Harvard Apparatus). Isometric tension was continuously monitored and recorded on an IBM-compatible PC with DATAQ data acquisition software (DATAQ Instruments). Resting passive tension was maintained throughout the experiments at 600-625 mg, which offered the maximal tension when the rings were exposed to 40 mM K ϩ . The rings were equilibrated for ϳ60 min at resting tension and then challenged two to three times with 40 mM K ϩ -containing perfusate to obtain a stable contractile response.
Isolated PA rings were superfused with modified Krebs solution (MKS; at 37°C) that contained (in mM) 138 NaCl, 4.7 KCl, 1.2 MgSO 4, 1.2 NaH2PO4, 5 HEPES, 1.8 CaCl2, and 10 glucose (pH 7.4). In the Ca 2ϩ -free solution, CaCl2 was replaced by equimolar MgCl2 and 1 mM EGTA was added to chelate residual Ca 2ϩ . In the high-K ϩ solution, NaCl was replaced by equimolar KCl to maintain osmolarity. PE, phentolamine, nifedipine, verapamil (Sigma), NiCl2, and LaCl3 were dissolved directly in the perfusate on the day of use. The pH values of all solutions were measured after addition of the drugs and readjusted to 7.4.
Cell preparation. To isolate PASMCs, the right and left branches of the main PA were isolated and incubated for 20 min in Hanks' solution containing 2 mg/ml of collagenase. The adventitia and endothelium were removed after the incubation. The remaining smooth muscle was digested with 0.5 mg/ml of elastase and 2.0 mg/ml of collagenase at 37°C. Single PASMCs were plated onto 25-mm coverslips (for patch-clamp and fluorescence experiments) and 10-cm petri dishes (for molecular biological experiments). The cells were incubated in a humidified atmosphere of 5% CO 2 in air at 37°C and cultured in 10% fetal bovine serum (FBS)-DMEM for 5-6 days before the experiment.
PA endothelial cells (PAECs) were obtained by gently scraping the intima of the PAs with a plastic cell lifter and seeding into a 10-cm petri dish containing 10% FBS-DMEM-F-12 medium. After incubation for 1 wk (5% CO 2 in air at 37°C), SMC contaminants were removed by pipette aspiration. The cultures were verified as endothelial cells by positive factor VIII staining and uptake of 1,1Ј-dioctadecyl-3,3,3Ј,3Ј-tetramethylindocarbocyanine perchlorate (DiI)-labeled acetylated low-density lipoprotein. PAECs were used for experimentation at passages 6-10 (23) .
Electrophysiological measurements. Whole cell I SOC was recorded with an Axopatch-1D amplifier and a DigiData 1200 interface with patch-clamp techniques (16, 43) . Patch pipettes (2-4 M⍀) were made on a Sutter electrode puller with borosilicate glass tubes and fire polished on a microforge. Voltage stimuli lasting 300 ms were delivered from a holding potential of 0 mV in voltage steps from Ϫ120 to ϩ20 mV (in 20-mV increments). Traces recorded before the activation of SOCs were used as a template to subtract leak currents. All experiments were performed at room temperature (22-24°C ]cyt was measured with the Ca 2ϩ -sensitive fluorescent indicator fura 2 and the quantitative fluorescence microscopy system (15, 43) . Cells were loaded with the acetoxymethyl ester form of fura 2 (fura 2-AM; 3 M for 30 min) in the dark at room temperature (22-24°C) under an atmosphere of 5% CO2-95% air. The fura 2-loaded cells on the coverslips were then transferred to a recording cell chamber mounted on a microscope stage and superfused with MKS for 30 min to remove the extracellular fura 2, which may have diffused out of the cell after initial loading, and to allow cytosolic esterases to cleave fura 2-AM into active fura 2. The fluorescence microscopy experiments were carried out at 32°C. Fura 2 fluorescence (510-nm light emission excited by 340-and 380-nm illumination) from the cell as well as background fluorescence was collected with Nikon UV-Fluor objectives. The fluorescence signals emitted from the cells were monitored continuously with an intracellular imaging fluorescence microscopy system and recorded on an IBM-compatible computer for later analysis. The 340-to 380-nm fluorescence ratio was used to indicate the changes in [Ca 2ϩ ]cyt in PASMCs treated with the various agonists. The resting [Ca 2ϩ ]cyt, calculated according to the method previously reported by Grynkiewicz et al. (15) , was 70 Ϯ 11 nM in rat PASMCs.
CPA (Sigma) was dissolved in DMSO to make a stock solution of 30 mM. Aliquots of the stock solution were then diluted 1:3,000 in the bath solution to make a final concentration of 10 M CPA (pH 7.4). In [Ca 2ϩ ]cyt and ISOC measurement experiments, the same amount of DMSO (0.03%) used for dissolving CPA was added to the control solutions. Vehicle (DMSO) alone had negligible effects on [Ca 2ϩ ]cyt and ISOC in PASMCs.
RT-PCR. Total RNA [3 g; 260-to 280-nm optical density (OD) ratio Ͼ 1.7] was prepared from single cells (PASMCs and PAECs) and brain tissues by the acid guanidinium thiocyanate-phenol-chloroform extraction method and reverse transcribed with random hexamers [pd(N)6 primer] (41). The sense and antisense primers chosen to amplify the cDNA were specifically designed from the coding regions of various TRPs (Table 1) . The fidelity and specificity of the sense and antisense oligos were examined with the BLAST program. PCR was performed by a GeneAmp PCR system with AmpliTaq DNA polymerase and accompanying buffers. The first-strand cDNA reaction mixture (3 l) was used in a 50-l PCR consisting of 0.2 nmol of each primer, 10 mM Tris ⅐ HCl, pH 8.3, 50 mM KCl, 2 mM MgCl 2, 200 M each deoxynucleotide triphosphate, and 2 U of Taq DNA polymerase. The cDNA samples were amplified in a DNA thermal cycler under the following conditions: the mixture was annealed at 52-61°C (1 min), extended at 72°C (2.0 min), and denatured at 94°C (1 min) for 20-30 cycles. This was followed by a final extension at 72°C (10 min) to ensure complete product extension. The PCR products were electrophoresed through a 2% agarose gel, and the amplified cDNA bands were visualized by ethidium bromide staining. To quantify the PCR products of TRPs, an invariant mRNA of smooth muscle ␤-actin was used as an internal control. Immediately after each experiment, the OD value for each band on the gel was measured by a gel documentation system. The OD values in TRP signals were normalized to the OD values in the ␤-actin signals. The normalized values are expressed as arbitrary units for quantitative comparison.
Statistical analysis. The composite data are expressed as means Ϯ SE. Statistical analyses were performed with unpaired Student's t-test or ANOVA and post hoc tests (Student-Newman-Keuls) where appropriate. Differences were considered to be significant when P Ͻ 0.05.
RESULTS

Requirement of extracellular Ca
2ϩ for pulmonary vasoconstriction. Cytosolic Ca 2ϩ stemming from extracellular fluids is important in triggering and maintaining agonist-mediated vasoconstriction. In isolated rat PA rings, removal of extracellular Ca 2ϩ almost abolished the active tension induced by 40 mM K ϩ or 2 M PE, an ␣-receptor agonist (Fig. 1A) . Chelation of extracellular Ca 2ϩ with 2 mM EGTA, which decreases free Ca 2ϩ concentration ([Ca 2ϩ ]) to ϳ0.5 M in MKS containing 1.8 mM CaCl 2 (10), had the same inhibitory effects on contractions induced by 40 mM K ϩ or PE (Fig. 1B) . Furthermore, extracellular application of the L-type VDCC blockers nifedipine (10 M) and verapamil (0.5 M) almost abolished the 40 mM K ϩ -induced active tension but only inhibited the PE-induced contraction by 35-45% (Fig. 2) . These observations indicate that PE induces PA contraction by activating multiple Ca 2ϩ entry pathways, whereas 40 mM K ϩ -induced PA contraction is solely dependent on the membrane depolarization-mediated opening of VDCCs (8, 24) .
CCE-mediated pulmonary vasoconstriction. In the absence of extracellular Ca 2ϩ , PE induced a transient contraction that was apparently due to Ca 2ϩ release from the SR (Fig. 3Ab) . Restoration of extracellular Ca 2ϩ in the presence of the ␣-receptor blocker phentolamine (1 M) and the VDCC blocker verapamil (0.5 M) caused a similar contraction that was apparently due to CCE triggered by PE-induced store depletion (Fig. 3Ac) . The CCE-mediated PA contraction in the presence of phentolamine and verapamil accounted for ϳ23% of the total peak contraction induced by PE in the presence of extracellular Ca 2ϩ (Fig. 3, Aa and B) . Removal of phentolamine further constricted the vessel in the presence of extracellular Ca 2ϩ , which presumably resulted from Ca 2ϩ influx through ROCs (Fig.  3Ab) . These results indicate that Ca 2ϩ release from the SR and CCE through SOCs both contribute to agonistmediated pulmonary vasoconstriction.
Enhancement of CCE-induced contraction in endothelium-denuded PA rings. CCE is also a pathway for raising [Ca 2ϩ ] cyt in PAECs (23) . An increase in [Ca 2ϩ ] cyt in PAECs stimulates nitric oxide (NO) synthesis and release, thereby causing PA relaxation (2) . Accordingly, functional removal of the endothelium in isolated rat PA rings, confirmed by the loss of acetylcholine-mediated vasodilation (Fig. 4A, left) , significantly enhanced the CCE-mediated PA contraction but negligibly affected the Ca 2ϩ release-mediated PA contraction (Fig. 4B) . The active tension due to CCE was 189 Ϯ 36 mg/mg in endothelium-intact PA rings (n ϭ 11) and 637 Ϯ 28 mg/mg in endothelium-denuded rings (P Ͻ 0.001; n ϭ 6), whereas the tension due to Ca 2ϩ release was 206 Ϯ 52 (n ϭ 27 rings) and 251 Ϯ 26 mg/mg (P ϭ 0.1; n ϭ 6 rings), respectively (Fig. 4B) . (18, 19) . Indeed, extracellular application of Ni 2ϩ (1 mM) or La 3ϩ (50 M) significantly and reversibly attenuated the CCE-mediated PA contraction (Fig. 5) .
CCE (Fig. 6A) .
The amplitude of the CCE-induced increase in [Ca 2ϩ ] cyt determined the magnitude of PA contraction induced by CCE. Consistent with the results that Ni 2ϩ , a SOC blocker (3, 18, 19) , reversibly inhibited the CCE-mediated contraction in isolated PAs (Fig. 5) , extracellular application of 1 mM Ni 2ϩ almost abolished the increase in [Ca 2ϩ ] cyt due to CCE in single PASMCs (Fig. 6) . Whole cell I SOC in single PASMCs. Cells were superfused with solutions containing 120 mM Na ϩ and 20 mM Ca 2ϩ and dialyzed with solutions containing 138 mM Cs ϩ and ϳ100 nM free Ca 2ϩ (Fig. 7A) . The holding potential was set at 0 mV to inactivate voltage-gated Na 2ϩ and Ca 2ϩ channels. Whole cell currents were elicited by 300-ms voltage steps from Ϫ120 to ϩ20 mV before and after application of CPA (10 M; Fig. 7Ba ) or PE (10 M; Fig. 8A) . Subtraction of the current recorded under control conditions from the current recorded during application of CPA revealed that I SOC was activated by the CPA-induced depletion of SR Ca 2ϩ (Fig. 7Bb ). The inward current was carried by Ca 2ϩ (and Na ϩ ), and the outward current was carried by Cs (Cs permeability ϭ Na permeability for SOCs) (18, 19) .
Activity of SOCs is the major determinant of the CCE amplitude, which, in turn, governs the magnitude of the PA contraction induced by CCE. The SOC blocker Ni 2ϩ (1 mM) caused a marked reduction in whole cell I SOC elicited by passive depletion of Ca 2ϩ from the SR with CPA (10 M for 15 min; Fig. 7 , B and C). Extracellular application of La 3ϩ , a selective blocker of SOCs, also significantly and reversibly reduced the whole cell I SOC induced by active depletion of SR Ca 2ϩ by PE (10 M for 10-12 min; Fig. 8 ). The similarity of the blockade effects of Ni 2ϩ (and La 3ϩ ) on CCE-induced PA contraction (Fig. 5) , CPA-induced increase in [Ca 2ϩ ] cyt due to CCE (Fig. 6) , and whole cell I SOC (Figs. 7 and 8 ) further suggests that CCE participates in pulmonary vasoconstriction.
Expression of TRP channels in PASMCs and PAECs. The SOCs involved in CCE are believed to be encoded by TRP genes (4, 5) . Two TRP transcripts, TRP1 and TRP5, were detected in both PASMCs and PAECs (Fig. 9A). Interestingly, expression of TRP2, TRP3, TRP4, and TRP6 was quite different between PASMCs and PAECs. TRP4 and TRP6 were detected only in PASMCs, whereas TRP3 was detectable only in PAECs (Fig. 9B) .
The mRNA expression of TRP2 appeared to be much greater in PAECs than in PASMCs (Fig. 9B) . Furthermore, TRP7 was not detected in PASMCs and PAECs but was strongly expressed in the rat brain (Fig. 9C) .
DISCUSSION
Pulmonary vasoconstriction greatly contributes to the elevated pulmonary vascular resistance in patients with pulmonary hypertension (32) . A rise in [Ca 2ϩ ] cyt in PASMCs is a major trigger for pulmonary vasoconstriction (1, 33, 34) . The results from this study demonstrate that 1) CCE contributes to the PE-induced contraction in isolated PA rings in the presence of the ␣-receptor blocker phentolamine and the VDCC blocker verapamil; 2) removal of the endothelium enhances the CCE-mediated PA contraction with little effect on the Ca 2ϩ release-mediated PA contraction; 3) the CPAmediated passive store depletion induces CCE by eliciting I SOC in single PASMCs; 4) the SOC blocker Ni 2ϩ (and La 3ϩ ) reduces the I SOC , attenuates CCE, and inhibits the CCE-induced PA contraction; and 5) the TRP genes that are believed to encode SOCs responsible for I SOC and CCE are heterogeneously expressed in PASMCs (TRP1, TRP2, TRP4, TRP5, and TRP6) and PAECs (TRP1, TRP3, and TRP5). These results suggest that CCE, putatively through TRP-encoded SOCs in PASMCs, is involved in agonist-mediated pulmonary vasoconstriction. Pathophysiologically, increases in CCE as a result of upregulated TRP expression and/or augmented SOC activity may play a role in the development of excessive pulmonary vasoconstriction in patients with pulmonary hypertension.
Role of Ca 2ϩ in vasoconstriction. A rise in [Ca 2ϩ ] cyt induced by vasoactive agonists in vascular SMCs has been well documented to initiate and maintain smooth muscle contraction (8, 33, 34) . When [Ca 2ϩ ] cyt rises, Ca 2ϩ binds to calmodulin, which activates myosin light chain kinase to phosphorylate myosin light chain. This phosphorylation increases the activity of myosin ATPase that hydrolyzes ATP, thereby releasing energy. Subsequent cycling of the myosin cross bridges produces displacement of the myosin filament in relation to the actin filament causing contraction (33, 34) .
In the absence of extracellular Ca 2ϩ , PE induced a transient (5-7 min) PA contraction and a small steadystate active tension. That phentolamine blocked the contraction in Ca 2ϩ -free solution suggests that 1) Ca 2ϩ release from intracellular stores and 2) Ca 2ϩ sensitization of contractile proteins are both involved in PEmediated PA contraction (1). After the PE-mediated transient contraction in the absence of extracellular Ca 2ϩ returned to baseline, restoration of extracellular Ca 2ϩ induced a sustained contraction in the presence of the ␣-receptor blocker phentolamine and the VDCC blocker verapamil. This contraction was independent of 1) activation of the ␣-receptor, 2) opening of VDCCs, and 3) the intact endothelium. In the absence of extracellular Ca 2ϩ , PE can actively deplete Ca 2ϩ from the SR by increasing Ins(1,4,5)P 3 production (9); therefore, activation of SOCs and induction of CCE may be the trigger for this contraction, which accounts for ϳ23% of the total active tension induced by PE. These results indicate that the PE-induced PA contraction is composed of at least four components: 1) a transient contraction due to Ca 2ϩ release from the SR, 2) a sustained contraction due to Ca 2ϩ influx through ROCs and VDCCs, 3) a gradually decreasing contraction due to CCE, and 4) a small, sustained Ca 2ϩ -independent contraction due to an increased Ca 2ϩ sensitivity of contractile proteins.
Regulation of [Ca 2ϩ ] cyt in PASMCs. The agonist-mediated increases in [Ca 2ϩ ] cyt usually consist of an initial Ca 2ϩ release from intracellular stores followed by a sustained Ca 2ϩ entry through sarcolemmal Ca 2ϩ channels (9) . The SR has been described as the most important intracellular Ca 2ϩ store in many cell types (5, 37 ] and intracellularly stored [Ca 2ϩ ] in the SR are ϳ1-2 mM, which is 10,000-to 20,000-fold greater than [Ca 2ϩ ] cyt (5) . Passive Ca 2ϩ influx (from the extracellular milieu) and release (from the SR) to the cytoplasm are, therefore, driven by the electrochemical gradient that causes [Ca 2ϩ ] cyt to rise without an expenditure of energy.
The Ca 2ϩ influx through sarcolemmal VDCCs is an important mechanism involved in agonist-mediated vasoconstriction. An important component of the PEinduced PA contraction is the sustained contraction due to Ca 2ϩ influx through L-type VDCCs. To determine the contribution of VDCC-independent mechanisms to the PE-induced PA contraction, we used both nifedipine and verapamil to block the L-type VDCC in PA rings. Blockade of VDCCs by nifedipine or verapamil (44) abolished the PA contraction induced by 40 mM K ϩ but only decreased the PE-mediated contraction by 35-45%. Because nifedipine and verapamil block L-type VDCCs by different mechanisms, these results clearly show that 55-65% of the PE-induced PA contraction are due to mechanisms other than Ca 2ϩ influx through VDCCs. In addition to opening VDCCs, PE triggers Ca 2ϩ release from intracellular stores and induces Ca 2ϩ influx through ROCs and SOCs. This is why nifedipine or verapamil only partially inhibited PE-mediated pulmonary contraction. Increasing the extracellular K ϩ concentration from 4.7 to 40 mM shifted the K ϩ equilibrium potential from Ϫ85 to Ϫ31 mV and caused membrane depolarization. Therefore, the 40 mM K ϩ -induced contraction, which is mainly due to membrane depolarization-mediated opening of VDCCs, was completely eliminated by the blockade of VDCCs.
In the absence of extracellular Ca 2ϩ , the time courses of the CPA-induced transient [Ca 2ϩ ] cyt rise (Fig. 6A ) and the PE-induced transient PA contraction (Fig. 3A,  b and ] cyt in PAECs, NO production, and pulmonary vasodilation (2). Our observations indicate that removal of the endothelium significantly enhances the CCE-mediated PA contraction and that multiple TRPs (TRP1, TRP2, TRP3, and TRP5) are expressed in PAECs. These results suggest that CCE through TRPencoded SOCs is also an important mechanism responsible for the agonist-mediated increases in [Ca 2ϩ ] cyt in PAECs (8, 23) . The resultant vasorelaxation may play a negative feedback role in controlling agonist-induced vasomotor tone.
Molecular identity of CCE channels in PASMCs. Electrophysiological studies on endogenous I SOC indicate that there are at least five types of SOCs based on the single-channel conductance: a Ͻ0.2-pS channel (17), a 3-to 5-pS channel (14, 35) , a 16-pS channel (21), a 36-to 40-pS channel (19) , and an 89-to 110-pS channel (20) . Because of the diversity and variability of biophysical and pharmacological properties of I SOC , SOCs are believed to be complex and heterogeneous in molecular composition and cellular regulation.
In excised membrane patches of mouse aortic smooth muscle cells, Trepakova et al. (35) identified a 3.4-pS SOC that was activated by 1,2-bis(2-aminophenoxy)-ethane-N,N,N,ЈNЈ-tetraacetic acid-or thapsigargininduced passive depletion of intracellular Ca 2ϩ stores. The 3.4-pS channel was also activated by a Ca 2ϩ influx factor released from platelets when intracellularly stored Ca 2ϩ was depleted by thapsigargin (35) . In cellattached membrane patches of human PASMCs, Golovina et al. (14) previously observed a 5.34-pS Ca 2ϩ channel that was activated by CPA-or thapsigargin-induced passive depletion of intracellular Ca 2ϩ stores (14) . These observations suggest that this 3-to 5-pS Ca 2ϩ -permeable SOC is a native store-operated channel in systemic and pulmonary vascular smooth muscle cells. It remains to be investigated whether active depletion of intracellular Ca 2ϩ stores with PE would activate this 3-to 5-pS channel in rat PASMCs.
Heterologous expression of TRP genes in Xenopus oocytes and mammalian cells causes the appearance of store depletion-activated Ca 2ϩ currents (25, 38, 46) and enhances the increase in [Ca 2ϩ ] cyt due to CCE (6, 39, 45) . These observations provide strong evidence that SOCs are made up of subunits encoded in TRP genes; the diversity and heterogeneity of I SOC and CCE may result from the homo-and heteromultimeric SOCs formed by multiple TRP subunits (4, 5) . It has been proposed in mammalian cells that TRP1, TRP2, TRP4, and TRP5 may form endogenous SOCs that are activated solely by store depletion, whereas TRP3, TRP6, and TRP7 may form the channels that are activated by both store depletion and the production of Ins(1,4,5)P 3 and diacylglycerol (4) .
In this study, we observed that 1) TRP1, TRP2, and TRP5 were ubiquitously expressed in both PASMCs and PAECs, 2) TRP3 was specifically expressed in PAECs, and 3) TRP4 and TRP6 were selectively expressed in PASMCs. The exclusive expression of TRP4 and TRP6 in PASMCs and of TRP3 in PAECs suggests that different cell types may use different TRP genes to express SOCs. Because PAECs lack VDCCs, TRP3-encoded Ca 2ϩ -permeable channels may also serve as an important ROC that can be activated by receptorinduced Ins(1,4,5)P 3 activation and diacylglycerol production (4, 5, 22) .
In summary, CCE is an important mechanism for triggering PA contraction by maintaining the sustained increase in [Ca 2ϩ ] cyt and refilling Ca 2ϩ into the SR in PASMCs. The endogenous SOCs responsible for I SOC and CCE in PASMCs may be formed heteromerically by multiple TRP gene products such as TRP1, TRP4, and TRP5. Upregulation of TRP gene expression and augmentation of I SOC and CCE may be involved in the excessive pulmonary vasoconstriction implicated in pulmonary hypertension. Drugs directed at inhibiting TRP expression or blocking SOCs may be helpful for the treatment of patients with pulmonary hypertension.
